Clinical Report: HHS Discontinues Federal Medicaid and CHIP Support for Gender-Affirming Procedures in Minors

Overview

The U.S. Department of Health and Human Services has enacted a policy to prohibit federal Medicaid and CHIP funding for gender-affirming procedures in minors, citing insufficient clinical evidence and potential long-term health risks.

Background

The topic of gender-affirming care for minors is critical due to ongoing debates surrounding the safety and efficacy of these interventions. The decision by HHS to discontinue federal funding is part of a reassessment of pediatric gender treatment protocols.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

• The final rule prohibits federal Medicaid and CHIP funds for gender-affirming procedures for minors.
• Secretary Robert F. Kennedy, Jr. emphasized the risks of irreversible harm associated with these procedures.
• CMS Administrator Dr. Mehmet Oz stated that the decision is based on insufficient evidence.
• The policy includes a tapering-off period of up to six months for children currently undergoing hormone therapy.
• The regulation does not affect the coverage of mental health services under Medicaid and CHIP.
• International evaluations influenced the decision to restrict funding for these procedures.

Clinical Implications

Healthcare providers should be aware of the new federal guidelines regarding funding for gender-affirming procedures in minors.

Conclusion

The HHS's decision to discontinue funding for gender-affirming procedures in minors marks a significant policy shift.

Related Resources & Content

1. Associated Press Health, AP News, 2026 -- States sue HHS over youth gender-affirming care declaration
2. MDSpire News, MDSpire News, 2026 -- HHS Questions Pediatric Gender Treatment Evidence
3. KFF Health News, KFF Health News, 2026 -- State Gender-Affirming Care Access in Limbo
4. AAP News, American Academy of Pediatrics, 2026 -- Proposed restrictions to gender-affirming care are a ‘baseless intrusion into the patient-physician relationship’
5. Kaiser Family Foundation (KFF) — Texas Emerges as Focus of New Trump Administration Actions to Limit Gender-Affirming Care
6. AAP: Proposed restrictions to gender-affirming care are a ‘baseless intrusion into the patient-physician relationship’ | AAP News | American Academy of Pediatrics
7. Mental Health of Youths Who Use Puberty Blockers | Equity, Diversity, and Inclusion | JAMA Network Open | JAMA Network
8. Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis - PubMed